This is the authors' abstract. We don't add key points for this paper.
) and prolonged retention (72 h). Intracellular co-localization confirmed mannose receptor-mediated uptake of the antigen-carrier complex. Flow cytometry revealed 84.0% dendritic cell recruitment and 67.6% splenic lymphocyte proliferation. Furthermore, antigen-loaded HNM-MNs demonstrated superior therapeutic efficacy in both the B16-F10 melanoma model and influenza B hemagglutinin (Hem) viral challenge model. This work introduces a dual-functional platform integrating mannose-targeted delivery and thermoresponsive release, offering an effective strategy to improve subunit vaccine efficacy by enabling precise antigen release and enhanced immune activation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: